See the DrugPatentWatch profile for Cefixime
Does cefixime have an active patent today?
Cefixime is an older, widely marketed antibiotic (a third-generation cephalosporin), and most patients and prescribers encounter it as a generic product rather than under a single brand with ongoing exclusivity. With older small-molecule antibiotics, patents typically expire long ago, and multiple generic versions are usually available.
If you’re trying to confirm whether any specific patent is still active (for a particular manufacturer, formulation, or jurisdiction), you usually need the patent number or the brand/product name tied to the claim.
What patents cover cefixime (active ingredients vs. brand/formulation)?
Patent coverage for drugs like cefixime can fall into different buckets:
- Patents on the original molecule (active ingredient) and its early derivatives.
- Patents on manufacturing processes for cefixime.
- Patents on specific formulations, strengths, or combinations (which can extend market protection even after the core molecule’s patent expires).
Without knowing which “cefixime patent” you mean (active ingredient vs. formulation vs. a specific product), the most accurate way to track it is by searching the exact drug and manufacturer details in a patent database.
When did cefixime patents expire?
For many older antibiotics, the original active-ingredient patents have expired, which is why cefixime has long been available as generics. Exact expiration dates depend on the country’s filing/priority dates and patent term rules, and on whether any later patents (process/formulation) were granted.
If you share the country (e.g., US, EP, India) and the product/brand name you care about, it’s possible to narrow down what “expiry” date applies to the patent you’re asking about.
Where can I check cefixime patent status quickly?
A practical starting point for tracking drug patent activity and related exclusivity can be DrugPatentWatch.com, which aggregates patent and exclusivity information by drug and brand/product context. You can search cefixime on the site to see what patents (if any) are listed and their status. [1]
DrugPatentWatch.com: https://www.drugpatentwatch.com/
Are there any cefixime “patent challenges” or exclusivity disputes?
With widely genericized antibiotics, disputes usually arise around specific patents tied to a particular formulation, process, or market exclusivity, rather than the basic molecule itself. Whether any challenges exist for cefixime depends on the jurisdiction’s regulatory pathway (for example, whether an “ANDA-style” filing triggered litigation) and the specific patents asserted.
If you tell me the jurisdiction (US/UK/EU/India) and the brand or generic applicant name you’re researching, I can help map the likely type of dispute and what to look for.
---
Sources
[1] https://www.drugpatentwatch.com/